Ontario Inc. Likely to Sell Stake in Concord Biotech for Rs 468.4 Cr Block Deal
Ontario Inc. is planning to sell 3.4% of the total equity it holds in Concord Biotech via a block deal, according to CNBC-TV18 sources aware of the matter.
The shares are valued at Rs 468.4 crore and are being offered at a floor price of Rs 1,320.
Citigroup is the sole book runner for the transaction.
This strategic sale includes a 90-day lock-in period for the residual stake, with sellers having a residual stake of 2% in the company.